BAMCO INC /NY/ - ARGENX SE ownership

ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of ARGENX SE
ValueSharesWeighting
Q3 2023$141,585,015
+45.2%
287,991
+15.1%
0.41%
+52.2%
Q2 2023$97,536,948
+5.2%
250,268
+0.5%
0.27%
-2.9%
Q1 2023$92,755,654
-32.8%
248,955
-31.7%
0.28%
-40.0%
Q4 2022$138,002,465
-6.3%
364,286
-12.7%
0.46%
-2.7%
Q3 2022$147,293,000
-7.6%
417,201
-0.8%
0.48%
-7.0%
Q2 2022$159,374,000
+0.8%
420,645
-16.1%
0.51%
+32.0%
Q1 2022$158,077,000
-19.9%
501,339
-11.0%
0.39%
-7.4%
Q4 2021$197,344,000
+18.7%
563,535
+2.3%
0.42%
+11.1%
Q3 2021$166,301,000
+0.8%
550,666
+0.4%
0.38%
-0.3%
Q2 2021$165,050,000
+21.4%
548,211
+11.0%
0.38%
+12.8%
Q1 2021$135,967,000
+24.1%
493,727
+32.6%
0.34%
+23.6%
Q4 2020$109,519,000
+41.1%
372,398
+25.9%
0.27%
+13.9%
Q3 2020$77,639,000
+29.3%
295,744
+10.9%
0.24%
+9.7%
Q2 2020$60,052,000
+110.8%
266,626
+23.3%
0.22%
+55.0%
Q1 2020$28,490,000
-40.3%
216,276
-27.3%
0.14%
-23.1%
Q4 2019$47,756,000
+47.3%
297,505
+4.6%
0.18%
+36.8%
Q3 2019$32,427,000
+22.0%
284,543
+51.6%
0.13%
+24.3%
Q2 2019$26,579,000
+5.2%
187,732
-7.2%
0.11%0.0%
Q1 2019$25,254,000
+26.8%
202,293
-2.4%
0.11%
+5.9%
Q4 2018$19,912,000
+33.4%
207,265
+5.3%
0.10%
+62.9%
Q3 2018$14,921,000
+0.4%
196,740
+9.6%
0.06%
-4.6%
Q2 2018$14,867,000
+24.5%
179,428
+20.8%
0.06%
+18.2%
Q1 2018$11,946,000
+26.5%
148,511
-0.7%
0.06%
+25.0%
Q4 2017$9,440,000149,5110.04%
Other shareholders
ARGENX SE shareholders Q3 2023
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 297,701$112,778,07070.21%
Artia Global Partners LP 85,204$32,277,83112.30%
Avoro Capital Advisors LLC 1,265,555$479,430,2017.16%
DCF Advisers, LLC 25,000$9,470,7506.40%
Eagle Health Investments LP 60,300$22,843,4495.27%
Avidity Partners Management LP 625,000$236,768,7505.13%
Bellevue Group AG 911,100$345,152,0134.58%
Fairmount Funds Management LLC 73,526$27,853,8554.42%
Paradigm Biocapital Advisors LP 89,556$33,926,4993.98%
RTW INVESTMENTS, LP 482,195$182,669,9323.73%
View complete list of ARGENX SE shareholders